Copyright Reports & Markets. All rights reserved.

Global Anti-tumor Injection Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032

Request for Sample of this report
Buy now

1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Market Analysis by Type
    • 1.3.1 Overview: Global Anti-tumor Injection Consumption Value by Type: 2021 Versus 2025 Versus 2032
    • 1.3.2 Paclitaxel Injection
    • 1.3.3 Cisplatin Injection
    • 1.3.4 Cyclophosphamide Injection
    • 1.3.5 Vincristine Injection
    • 1.3.6 Others
  • 1.4 Market Analysis by Application
    • 1.4.1 Overview: Global Anti-tumor Injection Consumption Value by Application: 2021 Versus 2025 Versus 2032
    • 1.4.2 Breast Cancer
    • 1.4.3 Stomach Cancer
    • 1.4.4 Ovarian Cancer
    • 1.4.5 Lung Cancer
    • 1.4.6 Cervical Cancer
    • 1.4.7 Endometrial Cancer
    • 1.4.8 Prostate Cancer
    • 1.4.9 Bladder Cancer
    • 1.4.10 Others
  • 1.5 Global Anti-tumor Injection Market Size & Forecast
    • 1.5.1 Global Anti-tumor Injection Consumption Value (2021 & 2025 & 2032)
    • 1.5.2 Global Anti-tumor Injection Sales Quantity (2021-2032)
    • 1.5.3 Global Anti-tumor Injection Average Price (2021-2032)

2 Manufacturers Profiles

  • 2.1 Roche(Genentech)
    • 2.1.1 Roche(Genentech) Details
    • 2.1.2 Roche(Genentech) Major Business
    • 2.1.3 Roche(Genentech) Anti-tumor Injection Product and Services
    • 2.1.4 Roche(Genentech) Anti-tumor Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.1.5 Roche(Genentech) Recent Developments/Updates
  • 2.2 Bayer
    • 2.2.1 Bayer Details
    • 2.2.2 Bayer Major Business
    • 2.2.3 Bayer Anti-tumor Injection Product and Services
    • 2.2.4 Bayer Anti-tumor Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.2.5 Bayer Recent Developments/Updates
  • 2.3 Novartis
    • 2.3.1 Novartis Details
    • 2.3.2 Novartis Major Business
    • 2.3.3 Novartis Anti-tumor Injection Product and Services
    • 2.3.4 Novartis Anti-tumor Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.3.5 Novartis Recent Developments/Updates
  • 2.4 Pfizer
    • 2.4.1 Pfizer Details
    • 2.4.2 Pfizer Major Business
    • 2.4.3 Pfizer Anti-tumor Injection Product and Services
    • 2.4.4 Pfizer Anti-tumor Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.4.5 Pfizer Recent Developments/Updates
  • 2.5 Amgen
    • 2.5.1 Amgen Details
    • 2.5.2 Amgen Major Business
    • 2.5.3 Amgen Anti-tumor Injection Product and Services
    • 2.5.4 Amgen Anti-tumor Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.5.5 Amgen Recent Developments/Updates
  • 2.6 Mabxience
    • 2.6.1 Mabxience Details
    • 2.6.2 Mabxience Major Business
    • 2.6.3 Mabxience Anti-tumor Injection Product and Services
    • 2.6.4 Mabxience Anti-tumor Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.6.5 Mabxience Recent Developments/Updates
  • 2.7 Luoxin Pharmaceutical
    • 2.7.1 Luoxin Pharmaceutical Details
    • 2.7.2 Luoxin Pharmaceutical Major Business
    • 2.7.3 Luoxin Pharmaceutical Anti-tumor Injection Product and Services
    • 2.7.4 Luoxin Pharmaceutical Anti-tumor Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.7.5 Luoxin Pharmaceutical Recent Developments/Updates
  • 2.8 Qilu Pharmaceutical
    • 2.8.1 Qilu Pharmaceutical Details
    • 2.8.2 Qilu Pharmaceutical Major Business
    • 2.8.3 Qilu Pharmaceutical Anti-tumor Injection Product and Services
    • 2.8.4 Qilu Pharmaceutical Anti-tumor Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.8.5 Qilu Pharmaceutical Recent Developments/Updates
  • 2.9 Zhejiang Borui Biopharmaceutical Co., Ltd. (Hisun Biopharmaceutical Co., Ltd.)
    • 2.9.1 Zhejiang Borui Biopharmaceutical Co., Ltd. (Hisun Biopharmaceutical Co., Ltd.) Details
    • 2.9.2 Zhejiang Borui Biopharmaceutical Co., Ltd. (Hisun Biopharmaceutical Co., Ltd.) Major Business
    • 2.9.3 Zhejiang Borui Biopharmaceutical Co., Ltd. (Hisun Biopharmaceutical Co., Ltd.) Anti-tumor Injection Product and Services
    • 2.9.4 Zhejiang Borui Biopharmaceutical Co., Ltd. (Hisun Biopharmaceutical Co., Ltd.) Anti-tumor Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.9.5 Zhejiang Borui Biopharmaceutical Co., Ltd. (Hisun Biopharmaceutical Co., Ltd.) Recent Developments/Updates
  • 2.10 Fuxing Medicine
    • 2.10.1 Fuxing Medicine Details
    • 2.10.2 Fuxing Medicine Major Business
    • 2.10.3 Fuxing Medicine Anti-tumor Injection Product and Services
    • 2.10.4 Fuxing Medicine Anti-tumor Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.10.5 Fuxing Medicine Recent Developments/Updates
  • 2.11 Yuekang Pharmaceutical
    • 2.11.1 Yuekang Pharmaceutical Details
    • 2.11.2 Yuekang Pharmaceutical Major Business
    • 2.11.3 Yuekang Pharmaceutical Anti-tumor Injection Product and Services
    • 2.11.4 Yuekang Pharmaceutical Anti-tumor Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.11.5 Yuekang Pharmaceutical Recent Developments/Updates
  • 2.12 Yuheng Pharmaceutical
    • 2.12.1 Yuheng Pharmaceutical Details
    • 2.12.2 Yuheng Pharmaceutical Major Business
    • 2.12.3 Yuheng Pharmaceutical Anti-tumor Injection Product and Services
    • 2.12.4 Yuheng Pharmaceutical Anti-tumor Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.12.5 Yuheng Pharmaceutical Recent Developments/Updates
  • 2.13 Hengrui Medicine
    • 2.13.1 Hengrui Medicine Details
    • 2.13.2 Hengrui Medicine Major Business
    • 2.13.3 Hengrui Medicine Anti-tumor Injection Product and Services
    • 2.13.4 Hengrui Medicine Anti-tumor Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.13.5 Hengrui Medicine Recent Developments/Updates
  • 2.14 Huiyu Pharmaceutical
    • 2.14.1 Huiyu Pharmaceutical Details
    • 2.14.2 Huiyu Pharmaceutical Major Business
    • 2.14.3 Huiyu Pharmaceutical Anti-tumor Injection Product and Services
    • 2.14.4 Huiyu Pharmaceutical Anti-tumor Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.14.5 Huiyu Pharmaceutical Recent Developments/Updates
  • 2.15 Changbaishan Pharmaceutical Co., Ltd.
    • 2.15.1 Changbaishan Pharmaceutical Co., Ltd. Details
    • 2.15.2 Changbaishan Pharmaceutical Co., Ltd. Major Business
    • 2.15.3 Changbaishan Pharmaceutical Co., Ltd. Anti-tumor Injection Product and Services
    • 2.15.4 Changbaishan Pharmaceutical Co., Ltd. Anti-tumor Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.15.5 Changbaishan Pharmaceutical Co., Ltd. Recent Developments/Updates
  • 2.16 Innovent Biologics (Suzhou) Co., Ltd.
    • 2.16.1 Innovent Biologics (Suzhou) Co., Ltd. Details
    • 2.16.2 Innovent Biologics (Suzhou) Co., Ltd. Major Business
    • 2.16.3 Innovent Biologics (Suzhou) Co., Ltd. Anti-tumor Injection Product and Services
    • 2.16.4 Innovent Biologics (Suzhou) Co., Ltd. Anti-tumor Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.16.5 Innovent Biologics (Suzhou) Co., Ltd. Recent Developments/Updates
  • 2.17 Yifan Pharmaceutical
    • 2.17.1 Yifan Pharmaceutical Details
    • 2.17.2 Yifan Pharmaceutical Major Business
    • 2.17.3 Yifan Pharmaceutical Anti-tumor Injection Product and Services
    • 2.17.4 Yifan Pharmaceutical Anti-tumor Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.17.5 Yifan Pharmaceutical Recent Developments/Updates

3 Competitive Environment: Anti-tumor Injection by Manufacturer

  • 3.1 Global Anti-tumor Injection Sales Quantity by Manufacturer (2021-2026)
  • 3.2 Global Anti-tumor Injection Revenue by Manufacturer (2021-2026)
  • 3.3 Global Anti-tumor Injection Average Price by Manufacturer (2021-2026)
  • 3.4 Market Share Analysis (2025)
    • 3.4.1 Producer Shipments of Anti-tumor Injection by Manufacturer Revenue ($MM) and Market Share (%): 2025
    • 3.4.2 Top 3 Anti-tumor Injection Manufacturer Market Share in 2025
    • 3.4.3 Top 6 Anti-tumor Injection Manufacturer Market Share in 2025
  • 3.5 Anti-tumor Injection Market: Overall Company Footprint Analysis
    • 3.5.1 Anti-tumor Injection Market: Region Footprint
    • 3.5.2 Anti-tumor Injection Market: Company Product Type Footprint
    • 3.5.3 Anti-tumor Injection Market: Company Product Application Footprint
  • 3.6 New Market Entrants and Barriers to Market Entry
  • 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

  • 4.1 Global Anti-tumor Injection Market Size by Region
    • 4.1.1 Global Anti-tumor Injection Sales Quantity by Region (2021-2032)
    • 4.1.2 Global Anti-tumor Injection Consumption Value by Region (2021-2032)
    • 4.1.3 Global Anti-tumor Injection Average Price by Region (2021-2032)
  • 4.2 North America Anti-tumor Injection Consumption Value (2021-2032)
  • 4.3 Europe Anti-tumor Injection Consumption Value (2021-2032)
  • 4.4 Asia-Pacific Anti-tumor Injection Consumption Value (2021-2032)
  • 4.5 South America Anti-tumor Injection Consumption Value (2021-2032)
  • 4.6 Middle East & Africa Anti-tumor Injection Consumption Value (2021-2032)

5 Market Segment by Type

  • 5.1 Global Anti-tumor Injection Sales Quantity by Type (2021-2032)
  • 5.2 Global Anti-tumor Injection Consumption Value by Type (2021-2032)
  • 5.3 Global Anti-tumor Injection Average Price by Type (2021-2032)

6 Market Segment by Application

  • 6.1 Global Anti-tumor Injection Sales Quantity by Application (2021-2032)
  • 6.2 Global Anti-tumor Injection Consumption Value by Application (2021-2032)
  • 6.3 Global Anti-tumor Injection Average Price by Application (2021-2032)

7 North America

  • 7.1 North America Anti-tumor Injection Sales Quantity by Type (2021-2032)
  • 7.2 North America Anti-tumor Injection Sales Quantity by Application (2021-2032)
  • 7.3 North America Anti-tumor Injection Market Size by Country
    • 7.3.1 North America Anti-tumor Injection Sales Quantity by Country (2021-2032)
    • 7.3.2 North America Anti-tumor Injection Consumption Value by Country (2021-2032)
    • 7.3.3 United States Market Size and Forecast (2021-2032)
    • 7.3.4 Canada Market Size and Forecast (2021-2032)
    • 7.3.5 Mexico Market Size and Forecast (2021-2032)

8 Europe

  • 8.1 Europe Anti-tumor Injection Sales Quantity by Type (2021-2032)
  • 8.2 Europe Anti-tumor Injection Sales Quantity by Application (2021-2032)
  • 8.3 Europe Anti-tumor Injection Market Size by Country
    • 8.3.1 Europe Anti-tumor Injection Sales Quantity by Country (2021-2032)
    • 8.3.2 Europe Anti-tumor Injection Consumption Value by Country (2021-2032)
    • 8.3.3 Germany Market Size and Forecast (2021-2032)
    • 8.3.4 France Market Size and Forecast (2021-2032)
    • 8.3.5 United Kingdom Market Size and Forecast (2021-2032)
    • 8.3.6 Russia Market Size and Forecast (2021-2032)
    • 8.3.7 Italy Market Size and Forecast (2021-2032)

9 Asia-Pacific

  • 9.1 Asia-Pacific Anti-tumor Injection Sales Quantity by Type (2021-2032)
  • 9.2 Asia-Pacific Anti-tumor Injection Sales Quantity by Application (2021-2032)
  • 9.3 Asia-Pacific Anti-tumor Injection Market Size by Region
    • 9.3.1 Asia-Pacific Anti-tumor Injection Sales Quantity by Region (2021-2032)
    • 9.3.2 Asia-Pacific Anti-tumor Injection Consumption Value by Region (2021-2032)
    • 9.3.3 China Market Size and Forecast (2021-2032)
    • 9.3.4 Japan Market Size and Forecast (2021-2032)
    • 9.3.5 South Korea Market Size and Forecast (2021-2032)
    • 9.3.6 India Market Size and Forecast (2021-2032)
    • 9.3.7 Southeast Asia Market Size and Forecast (2021-2032)
    • 9.3.8 Australia Market Size and Forecast (2021-2032)

10 South America

  • 10.1 South America Anti-tumor Injection Sales Quantity by Type (2021-2032)
  • 10.2 South America Anti-tumor Injection Sales Quantity by Application (2021-2032)
  • 10.3 South America Anti-tumor Injection Market Size by Country
    • 10.3.1 South America Anti-tumor Injection Sales Quantity by Country (2021-2032)
    • 10.3.2 South America Anti-tumor Injection Consumption Value by Country (2021-2032)
    • 10.3.3 Brazil Market Size and Forecast (2021-2032)
    • 10.3.4 Argentina Market Size and Forecast (2021-2032)

11 Middle East & Africa

  • 11.1 Middle East & Africa Anti-tumor Injection Sales Quantity by Type (2021-2032)
  • 11.2 Middle East & Africa Anti-tumor Injection Sales Quantity by Application (2021-2032)
  • 11.3 Middle East & Africa Anti-tumor Injection Market Size by Country
    • 11.3.1 Middle East & Africa Anti-tumor Injection Sales Quantity by Country (2021-2032)
    • 11.3.2 Middle East & Africa Anti-tumor Injection Consumption Value by Country (2021-2032)
    • 11.3.3 Turkey Market Size and Forecast (2021-2032)
    • 11.3.4 Egypt Market Size and Forecast (2021-2032)
    • 11.3.5 Saudi Arabia Market Size and Forecast (2021-2032)
    • 11.3.6 South Africa Market Size and Forecast (2021-2032)

12 Market Dynamics

  • 12.1 Anti-tumor Injection Market Drivers
  • 12.2 Anti-tumor Injection Market Restraints
  • 12.3 Anti-tumor Injection Trends Analysis
  • 12.4 Porters Five Forces Analysis
    • 12.4.1 Threat of New Entrants
    • 12.4.2 Bargaining Power of Suppliers
    • 12.4.3 Bargaining Power of Buyers
    • 12.4.4 Threat of Substitutes
    • 12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain

  • 13.1 Raw Material of Anti-tumor Injection and Key Manufacturers
  • 13.2 Manufacturing Costs Percentage of Anti-tumor Injection
  • 13.3 Anti-tumor Injection Production Process
  • 13.4 Industry Value Chain Analysis

14 Shipments by Distribution Channel

  • 14.1 Sales Channel
    • 14.1.1 Direct to End-User
    • 14.1.2 Distributors
  • 14.2 Anti-tumor Injection Typical Distributors
  • 14.3 Anti-tumor Injection Typical Customers

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Methodology
    • 16.2 Research Process and Data Source

    According to our (Global Info Research) latest study, the global Anti-tumor Injection market size was valued at US$ million in 2025 and is forecast to a readjusted size of US$ million by 2032 with a CAGR of %during review period.
    Anti-tumor injections are a class of drugs specifically used to treat tumors. They can inhibit the growth and spread of tumor cells through different mechanisms.
    This report is a detailed and comprehensive analysis for global Anti-tumor Injection market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
    Key Features:
    Global Anti-tumor Injection market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
    Global Anti-tumor Injection market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
    Global Anti-tumor Injection market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
    Global Anti-tumor Injection market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2021-2026
    The Primary Objectives in This Report Are:
    To determine the size of the total market opportunity of global and key countries
    To assess the growth potential for Anti-tumor Injection
    To forecast future growth in each product and end-use market
    To assess competitive factors affecting the marketplace
    This report profiles key players in the global Anti-tumor Injection market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Roche(Genentech), Bayer, Novartis, Pfizer, Amgen, Mabxience, Luoxin Pharmaceutical, Qilu Pharmaceutical, Zhejiang Borui Biopharmaceutical Co., Ltd. (Hisun Biopharmaceutical Co., Ltd.), Fuxing Medicine, etc.
    This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
    Market Segmentation
    Anti-tumor Injection market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
    Market segment by Type
    Paclitaxel Injection
    Cisplatin Injection
    Cyclophosphamide Injection
    Vincristine Injection
    Others
    Market segment by Application
    Breast Cancer
    Stomach Cancer
    Ovarian Cancer
    Lung Cancer
    Cervical Cancer
    Endometrial Cancer
    Prostate Cancer
    Bladder Cancer
    Others
    Major players covered
    Roche(Genentech)
    Bayer
    Novartis
    Pfizer
    Amgen
    Mabxience
    Luoxin Pharmaceutical
    Qilu Pharmaceutical
    Zhejiang Borui Biopharmaceutical Co., Ltd. (Hisun Biopharmaceutical Co., Ltd.)
    Fuxing Medicine
    Yuekang Pharmaceutical
    Yuheng Pharmaceutical
    Hengrui Medicine
    Huiyu Pharmaceutical
    Changbaishan Pharmaceutical Co., Ltd.
    Innovent Biologics (Suzhou) Co., Ltd.
    Yifan Pharmaceutical
    Market segment by region, regional analysis covers
    North America (United States, Canada, and Mexico)
    Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
    South America (Brazil, Argentina, Colombia, and Rest of South America)
    Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
    The content of the study subjects, includes a total of 15 chapters:
    Chapter 1, to describe Anti-tumor Injection product scope, market overview, market estimation caveats and base year.
    Chapter 2, to profile the top manufacturers of Anti-tumor Injection, with price, sales quantity, revenue, and global market share of Anti-tumor Injection from 2021 to 2026.
    Chapter 3, the Anti-tumor Injection competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
    Chapter 4, the Anti-tumor Injection breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
    Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
    Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and Anti-tumor Injection market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
    Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
    Chapter 13, the key raw materials and key suppliers, and industry chain of Anti-tumor Injection.
    Chapter 14 and 15, to describe Anti-tumor Injection sales channel, distributors, customers, research findings and conclusion.

    Buy now